mrs CONNIE WOODBURN

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 160: Protect Medical Innovation Act and S 149: Medical Device Access and Innovation Protection Act; (All provisions; including but not limited to Section 2 related to the area of the medical device tax, as well as applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

HR 160: Protect Medical Innovation Act and S 149: Medical Device Access and Innovation Protection Act; (All provisions; including but not limited to Section 2 related to the area of the medical device tax, as well as applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

HR 160: Protect Medical Innovation Act and S 149: Medical Device Access and Innovation Protection Act; (All provisions; including but not limited to Section 2 related to the area of the medical device tax, as well as applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

HR 160: Protect Medical Innovation Act and S 149: Medical Device Access and Innovation Protection Act; (All provisions; including but not limited to Section 2 related to the area of the medical device tax, as well as applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

HR 592 and S 314: Pharmacy and Medically Underserved Areas Enhancement Act: To amend the Social Security Act to provide coverage under the Medicare program for pharmacist servcies. (All provisions.)

S 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; Section 3 All portions regarding Amendments to Controlled Substance Monitoring Program General Issues regarding prescription drug abuse

S 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; Section 3: All portions regarding Amendments to Controlled Substance Monitoring Program S. 524; Comprehensive Addiction and Recovery Acto of 2015; all sections General Issues regarding prescription drug abuse

S 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; Section 3: All portions regarding Amendments to Controlled Substance Monitoring Program S. 524; Comprehensive Addiction and Recovery Acto of 2015; all sections General Issues regarding prescription drug abuse

S 524: Comprehensive Addiction and Recovery Act of 2015; Section 601:State Demonstration Grants for Comprehensive Opioid Abuse Response General Issues regarding prescription drug abuse

S 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; Section 3: All portions regarding Amendments to Controlled Substance Monitoring Program S. 524; Comprehensive Addiction and Recovery Acto of 2015; all sections General Issues regarding prescription drug abuse

S 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015; Section 3: All portions regarding Amendments to Controlled Substance Monitoring Program S. 524; Comprehensive Addiction and Recovery Acto of 2015; all sections General Issues regarding prescription drug abuse

HR 3204: Update on the Drug Quality and Security Act; Title II - Drug Supply Chain Security; All provisions related to distribution integrity and licensing.

HR 3204; Update on the Drug Quality and Security Act; Title II - Drug Supply Chain Security; All provisions related to distribution integrity.

H. R. 4069 and H.R. 4709: "Ensuring Patient Access and Effective Drug Enforcement Act of 2013" (All provisions, including Section 2, Registration Process Under Controlled Substances Act and Section 3, Combating Prescription Drug Abuse Working Group.)

H. R. 4069; "Ensuring Patient Access and Effective Drug Enforcement Act of 2013" (All provisions, including Section 2, Registration Process Under Controlled Substances Act, and Section 3, Combating Prescription Drug Abuse Working Group.)

H. R. 4190; To amend the Social Security Act to provide coverage under the Medicare program of pharmacist services; All provisions. General issues related to the Medicare Competitive Bidding Program.

H. R. 4190: To amend the Social Security Act to provide coverage under the Medicare program of pharmacist services. (All provisions.) General issues relsted to the Medicare Competitive Bidding Program.

H. R. 4069 and H.R. 4709: "Ensuring Patient Access and Effective Drug Enforcement Act of 2013" (All provisions, including Section 2, Registration Process Under Controlled Substances Act and Section 3, Combating Prescription Drug Abuse Working Group.)

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Devices Access and Innovation Prevention Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Devices Access and Innovation Prevention Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting method.

H. R. 523: "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

S. 2839: To authorize the Attorney General to award grants to address the national epidemic of prescription opiod abuse and heroin use. (Section 601: State Demonstration Grants for Comprehensive Opiod Abuse Response.) General isuses regarding the prescription drug epidemic.

S. 2839: To authorize the Attorney General to award grants to address the national epidemic of prescription opioid abuse and heroin use (Section 601: State Demonstration Grants for Comprehensive Opioid Abuse Response.) General issues regarding prescription drug abuse.

S. 621/HR 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

S. 621/H.R. 1285: "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the physical security requirements for storing hydrocodone products.)

S. 621/HR 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

S. 621/H.R. 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

HR 1919; Safeguarding America's Pharmaceuticals Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; the Drug Supply Chain Secruity Act; and S. 959, the Pharmaceutical Compounding Quality and Accountability Act, as amended to include the text of S. 957 as Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity.

HR 1919; Safegaurding America's Pharmaceutcials Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chain Security Act, and S. 959, the Pharmaceuticals Compounding Quality and Accountability Act, as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity. HR 3204; "Drug Quality and Security Act"; Title II; all provsions relating to pharmaceutical distribution integrity.

HR 1919; Safegaurding America's Pharmaceutcials Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chain Security Act, and S. 959, the Pharmaceuticals Compounding Quality and Accountability Act, as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity. HR 3204; "Drug Quality and Security Act"; Title II; all provsions relating to pharmaceutical distribution integrity.

H.R. 523; "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H. R. 523, "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions,including but not limited to Section 2 related to the repeal of the medical device tax as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H.R. 523; "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H.R. 523; "Protect Medical Innovation Act" and S.232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H.R. 523; "Protect Medical Innovation Act" and S.232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H. R. 523, "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions,including but not limited to Section 2 related to the repeal of the medical device tax as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H.R. 523; "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

H.R. 523; "Protect Medical Innovation Act" and S. 232, "Medical Device Access and Innovation Protection Act" (All provisions, including but not limited to Section 2 related to the repeal of the medical device tax, as well as the applicability to convenience kits.) General issues related to the retention of last-in, first-out inventory accounting methods.

S. 621/H.R. 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

S. 621/HR 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

S. 621/H.R. 1285: "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the physical security requirements for storing hydrocodone products.)

S. 621/HR 1285; "Safe Prescribing Act of 2013" (All provisions, including but not limited to Section 2, related to the Physical Security Requirements for storing hydrocodone products.)

HR 1919; Safegaurding America's Pharmaceutcials Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chain Security Act, and S. 959, the Pharmaceuticals Compounding Quality and Accountability Act, as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity. HR 3204; "Drug Quality and Security Act"; Title II; all provsions relating to pharmaceutical distribution integrity.

HR 1919; Safeguarding America's Pharmaceuticals Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; the Drug Supply Chain Secruity Act; and S. 959, the Pharmaceutical Compounding Quality and Accountability Act, as amended to include the text of S. 957 as Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity.

HR 4304; "The Drug Quality and Security Act"; Title II- Drug Supply Chain Security; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chaan Security Act, and S. 959, "The Pharmaceutical Compounding Quality and Accountability Act", as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity.

HR 1919; Safegaurding America's Pharmaceutcials Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chain Security Act, and S. 959, the Pharmaceuticals Compounding Quality and Accountability Act, as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity. HR 3204; "Drug Quality and Security Act"; Title II; all provsions relating to pharmaceutical distribution integrity.

HR 1919; Safeguarding America's Pharmaceuticals Act of 2013; All provisions relating to pharmaceutical distribution integrity. S. 957; the Drug Supply Chain Secruity Act; and S. 959, the Pharmaceutical Compounding Quality and Accountability Act, as amended to include the text of S. 957 as Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity.

HR 4304; "The Drug Quality and Security Act"; Title II- Drug Supply Chain Security; All provisions relating to pharmaceutical distribution integrity. S. 957; The Drug Supply Chaan Security Act, and S. 959, "The Pharmaceutical Compounding Quality and Accountability Act", as amended to include the text of Title II, Drug Supply Chain Security; all provisions relating to pharmaceutical distribution integrity.

S. 3187, "Food and Drug Administration Safety and Innovation Act". (Draft comments by bicameral staff; provisions relating to pharmaceutical distribution integrity not included in the final bill).

H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)

H.R.3839; Drug Shortage Prevention Act 2012; Section 3: Actions by the Food and Drug Adminstration to Address Critical Drug Shortages; Energy and Commerce User Fee Discussion Draft; Section 901: Discontinuance and Interruption of Manufacturing of Certain Drugs ; Section 905: Study on Drug Shortages; and Section 906: Annual Report on Drug Shortages.

H. R. 436, "Health Care Cost Reduction Act of 2012" (All provisions, including but not imited to Section 2, related to the Repeal of the Medical Device Tax)

H. R. 436, "Health Care Cost Reduction Act of 2012" (All provisions,including but not limited to Section 2, related to the Repeal of the Medical Device Tax as well as the applicability to convenience kits.)

H.R. 436, "Health Care Cost Reduction Act of 2012"" (All provisions, including but not limited to Section 2, related to the Repeal of the Medical Device Tax) General issues related to the retention of last-in, first-out inventory accounting methods.

H. R. 5853, "Gray Market Drug Reform and Transparency Act"' (All provisions, including but not limited to Section 2, related to Prohibition Against Wholesale Distributors Purchasing Prescription Drugs From Pharmacies, Section 3 related to Reporting by Wholesale Distributors of Prescription Drugs and Section 4, related to Identification of Sales Price for Drugs in Shortage) Advocacy on Prescription Drug Abuse (no bills)

H.R. 5853, "Gray Market Drug Reform and Transparency Act" (All provisions, including but not limited to Section 2, related to Prohibition Against Wholesale Distributors Purchasing Prescription Drugs From Pharmacies, Section 3 related to Reporting By Wholesale Distributors of Prescription Drugs and Section 4, related to Identification of Sales Prices for Drugs in Shortage) Advocacy on Prescription Drug Abuse (no bills)

HR 2483, "Whistleblower Improvement Act of 2011" (provisions in section 2 related to Amendments to the Securities Act of 1934)

H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)

HR 3026, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System)

Draft Legislation in House of Representatives: Safeguarding America's Pharmacetuicals Act HR 436: Protect Medical Innovation Act of 2011 (all provisions) S 17: Medical Device Access and Innovation Protection Act (all provisions)

HR 436, "Protect Medical Innovations Act of 2011" (all provisions) HR 5839, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System and Section 8, Requirements for Licensure of Wholesale Distributors)

Draft Legislation in House of Representatives; Safeguarding America's Pharmaceuticals Act HR 436: Protect Medical Innovation Act of 2011 (all provisions) S 17: Medical Device Access and Innovation Protection Act (all provisions)

Draft Legislation in House of Representatives; Safeguarding America's Pharmaceuticals Act (issues related to track and trace) HR 436: Protect Medical Innovations Act of 2011 (all provisions) S 17: Medical Device Access and Innovation Protection Act (all provisions)

HR 436, "Protect Medical Innovations Act of 2011" (all provisions) HR 5839, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System and Section 8, Requirements for Licensure of Wholesale Distributors)

H. R. 3590, The Patient Protection and Affordable Care Act, Section 10904, Modification of Annual Fee on Medical Device Manufacturers and Importers and H. R. 4872, The Health Care and Education Reconciliation Act, Section 1405, The Excise Tax on Medical Device Manufacturers.

H. R. 3590, The Patient Protection and Affordable Care Act, Section 10904, Modification of Annual Fee on Medical Device Manufacturers and Importers and H. R. 4872, The Health Care and Education Reconciliation Act, Section 1405, The Excise Tax on Medical Device Manufacturers.

H.R. 1392, Section 1: Exclusion of Customary Prompt Pay Discounts Extended to Wholesalers from Manufacturers' Average Sale Price for Payments for Drugs and Biologicals Under Medicare Part B.

H. R. 1765, Section 1. Medicare Payment for Items and Services Relating to the Furnishing of Intravenous Immune Globublin (IVIG) in a Patient's Home for the Treatment of Primary Immune Deficiency Dieases and S. 701, the Medicare Patient IVIG Access Act, Section 4. Coverage and Payment of Intravenous Immune Globulin in the Home.

H. R. 1765, Section I, Medicare Payment for Items and Services Relating to the Furnishing of Intravenous Immune Globulin (IVIG) in a Patient's Home for the Treatment of Primary Immune Deficiency Diseases and S. 701, the Medicare Patient IVIG Access Act, Section 4. Coverage and Payment of Intravenous Immune Globulin in the Home

A proposal to repeal the use of LIFO (last-in, first-out) inventory accounting method for Federal income tax purposes contained within the Administration's Fiscal Year 2010 Revenue Proposals and therefore, possibly in HR 3200 and Senate Health Reform bill.

H. R. 3276, Section 3: Improving the Reliability of Domestic Medical Isoptope Supply and Section 6: Domestic Medical Isotope Production

H. R. 1765, Section 1. Medicare Payment for Items and Services Relating to the Furnishing of Intravenous Immune Globublin (IVIG) in a Patient's Home for the Treatment of Primary Immune Deficiency Dieases and S. 701, the Medicare Patient IVIG Access Act, Section 4. Coverage and Payment of Intravenous Immune Globulin in the Home.

H. R. 1765, Section I, Medicare Payment for Items and Services Relating to the Furnishing of Intravenous Immune Globulin (IVIG) in a Patient's Home for the Treatment of Primary Immune Deficiency Diseases and S. 701, the Medicare Patient IVIG Access Act, Section 4. Coverage and Payment of Intravenous Immune Globulin in the Home

H. R. 3590, The Patient Protection and Affordable Care Act, Section 10904, Modification of Annual Fee on Medical Device Manufacturers and Importers and as proposed in previous healthcare reform legislation in the Senate, and H.R. 3962, The Affordable Health Care for America Act, Subtitle B - Other Revenue Provisions; Section 552: Excise Tax on Medical Devices

H. R. 3590, The Patient Protection and Affordable Care Act, Section 10904, Modification of Annual Fee on Medical Device Manufacturers and Importers and as proposed in previous healthcare reform legislation in the Senate, and H.R. 3962, The Affordable Health Care for America Act, Subtitle B - Other Revenue Provisions; Section 552: Excise Tax on Medical Devices

Medicaid pharmacy reimbursement and related provisions in the following bills: S. 1951, Fair Medicaid Drug Payment Act; and HR 3140, Saving Our Communities Pharmacy Act

Medicaid pharmacy reimbursement and related provisions in the following bills: S. 1951, Fair Medicaid Drug Payment Act, HR 3140, Saving Our Community Pharmacies Act; and S. 3101/HR 6331, Medicare Improvements for Patients and Providers Act (Section 203, Pharmacy Reimbursement Under Medicaid).

Medicaid pharmacy reimbursement and related provisions in the following bills: S. 1951 Fair Medicaid Drug Payment Act, HR 3140, Saving Our Community Pharmacies Act; and S. 3101/HR 6331, Medicare Improvements for Patients and Providers Act (Section 203 Pharmacy Reimbursement Under Medicaid).

Medicare pharmacy reimbursement and related provisions in the following bills: S. 1951, Fair Medicaid Drug Payment Act; HR 3140, Saving Our Community Pharmacies Act; and S. 3101/HR 6331, Medicare Improvements for Patients and Providers Act (Section 203, Pharmacy Reimbursement Under Medicaid).

Federal pedigree legislation including HR 5839, Safeguarding America's Pharmaceuticals Act of 2008 and possible amendments to HR 3160, Food and Drug Safety Import Act and healthcare associated infections/MRSA.

Federal pedigree legislation including HR 5839, Safeguarding America's Pharmaceuticals Act of 2008 and possible amendments to HR 3160, Food and Drug Safety Import Act and healthcare associated infections/MRSA.

Federal pedigree legislation including HR 5839, Safeguarding America's Pharmaceuticals Act of 2008 and possible amendment to HR 3160, Food and Drug Safety Import Act and Healthcare associated infections/MRSA.

Federal Food, Drug and Cosmetic Act provisions affecting pharmaceutical supply chain and distribution, including proposed amendment on federal pharmaceutical pedigree to H. R. 3160, Food and Drug Safety Import Act of 2007 Healthcare assoicated infections/MRSA

Federal pedigree legislation including HR 5839, Safeguarding America's Pharmaceuticals Act of 2008 and possible amendments to HR 3160, Food and Drug Safety Import Act and healthcare associated infections/MRSA.